• 3317 Citations
  • 30 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David M. Loeb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Publications

    Enolate-forming compounds provide protection from platinum neurotoxicity

    Geohagen, B. C., Weiser, D. A., Loeb, D. M., Nordstroem, L. U. & LoPachin, R. M., Feb 1 2020, In : Chemico-Biological Interactions. 317, 108961.

    Research output: Contribution to journalArticle

  • Association of dasatinib with progression-free survival among patients with advanced gastrointestinal stromal tumors resistant to imatinib

    Schuetze, S. M., Bolejack, V., Thomas, D. G., Von Mehren, M., Patel, S., Samuels, B., Choy, E., D'Amato, G., Staddon, A. P., Ganjoo, K. N., Chow, W. A., Rushing, D. A., Forscher, C. A., Priebat, D. A., Loeb, D. M., Chugh, R., Okuno, S., Reinke, D. K. & Baker, L. H., Jun 2018, In : JAMA Oncology. 4, 6, p. 814-820 7 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Consensus and controversies regarding the treatment of rhabdomyosarcoma

    Borinstein, S. C., Steppan, D., Hayashi, M., Loeb, D. M., Isakoff, M. S., Binitie, O., Brohl, A. S., Bridge, J. A., Stavas, M., Shinohara, E. T., Meyer, W. H., Reed, D. R. & Wagner, L. M., Feb 1 2018, In : Pediatric Blood and Cancer. 65, 2, e26809.

    Research output: Contribution to journalReview article

  • 19 Scopus citations

    Knock-In of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

    Annesley, C. E., Rabik, C., Duffield, A. S., Rau, R. E., Magoon, D., Li, L., Huff, V., Small, D., Loeb, D. M. & Brown, P., Oct 1 2018, In : Oncotarget. 9, 82, p. 35313-35326 14 p.

    Research output: Contribution to journalArticle

  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

    Jacobsohn, D. A., Loken, M. R., Fei, M., Adams, A., Brodersen, L. E., Logan, B. R., Ahn, K. W., Shaw, B. E., Kletzel, M., Olszewski, M., Khan, S., Meshinchi, S., Keating, A., Harris, A., Teira, P., Duerst, R. E., Margossian, S. P., Martin, P. L., Petrovic, A., Dvorak, C. C. & 29 others, Nemecek, E. R., Boyer, M. W., Chen, A. R., Davis, J. H., Shenoy, S., Savasan, S., Hudspeth, M. P., Adams, R. H., Lewis, V. A., Kheradpour, A., Kasow, K. A., Gillio, A. P., Haight, A. E., Bhatia, M., Bambach, B. J., Haines, H. L., Quigg, T. C., Greiner, R. J., Talano, J. A. M., Delgado, D. C., Cheerva, A., Gowda, M., Ahuja, S., Ozkaynak, M., Mitchell, D., Schultz, K. R., Fry, T. J., Loeb, D. M. & Pulsipher, M. A., Oct 2018, In : Biology of Blood and Marrow Transplantation. 24, 10, p. 2040-2046 7 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations